HIV/AIDS
Researchers' findings from the United States advance HIV/AIDS research
Published in AIDS Weekly, October 2nd, 2006
Study 1: Randomized trials are needed to determine whether adult male circumcision would reduce the risk of acquiring HIV infection.
"While the HIV pandemic persists, and randomized clinical trials to evaluate the effectiveness of mate circumcision as an HIV prevention measure are underway with initial results being released, there is still much debate on the implications of these studies as well as on the feasibility of such a measure.
"This paper summarizes and discusses the main findings of studies of the evidence underlying adult mate circumcision to prevent...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-10-02)
More Articles from AIDS Weekly
- HIV/AIDS HAART
Fosamprenavir-ritonavir similar in safety and efficacy as lopinavir-ritonavir in HIV/AIDS - HIV/AIDS Pathogenesis
HIV-1 integration in untreated infection occurs preferentially within genes - HIV/AIDS Prognostics
Serum albumin predicts severity of HIV infection and monitors response to HAART - HIV/AIDS Therapy
Virological response, not mortality improved in first decade of HAART use in HIV/AIDS - Apoptosis
Azidothymidine in adult T cell leukemia/lymphoma patients results in tumor cell death - Blood Safety
Precautions necessary during hand surgery on patients at high-risk for blood-borne viruses - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
